2. Definitions
The law of December 29, 2011 on reinforcing the safety of medicines and health products states that the purpose of pharmacovigilance is to monitor, assess, prevent and manage the risk of adverse reactions resulting from the use of medicines and products mentioned in Article L 5121-1.
Pharmacovigilance applies in particular to all drugs benefiting from a Marketing Authorization (AMM), a Temporary Use Authorization (ATU) or a Temporary Use Recommendation (RTU), and is based on :
the collection of adverse reactions based on spontaneous reporting by healthcare professionals, patients, approved patient associations and manufacturers, with the support...
You do not have access to this resource.
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed?
Log in!
Ongoing reading
Definitions